权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Differential Effects of TcdB1 and TcdB2 in C. difficile disease

TcdB1 和 TcdB2 在艰难梭菌疾病中的不同作用

基本信息

批准号：
10548849
负责人：
Jimmy D. Ballard
金额：
$ 43.23万
依托单位：
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
依托单位国家：
美国
项目类别：
财政年份：
2015
资助国家：
美国
起止时间：
2015-08-07 至 2025-01-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10548849
关键词：
Accounting Address Animal Model Antigen Presentation Antigens Attenuated Bacterial Toxins Binding Biochemical CRISPR/Cas technology Cell Communication Cell Surface Receptors Cells Cessation of life Characteristics Clostridium difficile Complementarity Determining Regions Data Development Disease Endocytosis Endonuclease I Epidemic Frequencies Genes Glucosyltransferase Hamsters Hospitals Human Humoral Immunities Immunologic Memory Immunosuppression In Vitro Infection Intoxication Investigation Knowledge Mediating Memory B-Lymphocyte Molecular Monomeric GTP-Binding Proteins Mutation Pathogenesis Patients Penetration Peptides Proteins Publishing Receptor Cell Relapse Reporting Reproduction spores Research Role Severity of illness System Testing Therapeutic Time Toxic effect Toxin Tropism United States Vaccination Vaccine Antigen Variant Virulence Virulence Factors Work cell type cytotoxicity experimental study gastrointestinal immunogenicity in vivo inhibitor insight mouse model mutant novel pathogen prevent programs receptor receptor binding response tissue tropism

项目摘要

ABSTRACT The most recent reports indicate Clostridioides difficile is the cause of over 400,000 cases of gastrointestinal illness and nearly 30,000 deaths annually. A major factor in the virulence of C. difficile is TcdB, an intracellular bacterial toxin that glucosylates small GTPases in targeted cells. Our studies focus on determining the critical differences in TcdB1 and TcdB2, the two major variants of TcdB. TcdB1 is produced by historical strains of C. difficile and TcdB2 is produced by hypervirulent/epidemic strains of C. difficile. Understanding how these two forms of TcdB, which share 92% identity, differ in critical steps in intoxication and immunogenicity provides insight into underlying differences in virulence between historical and epidemic strains of C. difficile. Several studies, including many from our group, have found that TcdB1 and TcdB2 differ in their interactions with target cells, tropism, cytotoxicity, and immunogenicity. The objective of our work is to identify and characterize the underlying molecular and cellular details of the factors accounting for these differences in TcdB1 and TcdB2 activity. To continue this line of investigation, three specific aims to i) Determine the underlying differences in the molecular mechanism of TcdB1 and TcdB2 receptor binding and cell penetration, ii) Determine if TcdB2 subverts antigen presentation and limits humoral immunity to co-administered vaccine antigen TcdB2Δ1769-1787, and iii) Construct and test strains of C. difficile expressing mutants of TcdB1 and TcdB2 will be pursued. These studies will provide further insight into the differences in TcdB1 and TcdB2, determine the contribution of TcdB to ineffective immune memory leading to relapse, and test hypotheses related to specific TcdB functional activities in the context of C. difficile infection. Overall, the findings from this work will enhance our understanding of C. difficile disease at multiple levels and provide information needed to prevent and treat this serious human illness.

摘要